Innovex International (INVX) holders sell 5M shares at $28.71 in secondary deal
Rhea-AI Filing Summary
Innovex International, Inc. entered into an Underwriting Agreement on August 6, 2026 with affiliates of Amberjack Capital Partners, L.P. as selling stockholders and Barclays Capital Inc. as underwriter for an underwritten secondary offering of common stock.
The selling stockholders sold 5,000,000 shares of Innovex common stock, par value $0.01 per share, to the underwriter at a price of $28.71 per sharereceived no proceeds from the sale. The secondary offering was conducted under an effective shelf registration statement on Form S-3 (File No. 333-282178), including a base prospectus dated September 17, 2024 and prospectus supplements dated August 6 and August 10, 2026. The agreement includes customary representations, warranties, conditions, termination rights and indemnification of the underwriter by the company and the selling stockholders.
Positive
- None.
Negative
- None.
Filing Explained
The secondary offering closed on
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Secondary shares sold: 5,000,000 shares
Underwriter purchase price: $28.71 per share
Shelf registration file number: File No. 333-282178
+3 more
6 metrics
Secondary shares sold
5,000,000 shares
Common stock sold by selling stockholders in underwritten offering
Underwriter purchase price
$28.71 per share
Price to underwriter for Innovex common stock in the offering
Shelf registration file number
File No. 333-282178
Form S-3 shelf registration used for the offering
Shelf effectiveness date
October 1, 2024
Date Form S-3 shelf registration became effective
Underwriting Agreement date
August 6, 2026
Date Innovex executed Underwriting Agreement with selling stockholders and underwriter
Offering closing date
August 10, 2026
Date the secondary offering of Innovex common stock closed
Key Terms
Underwriting Agreement, shelf registration statement, base prospectus, prospectus supplement, +1 more
5 terms
Underwriting Agreement financial
"entered into an Underwriting Agreement with certain affiliates of Amberjack Capital Partners"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
shelf registration statement regulatory
"made pursuant to the Company’s effective shelf registration statement on Form S-3"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
base prospectus regulatory
"which consists of a base prospectus, filed with the SEC on September 17, 2024"
A base prospectus is a detailed document that provides essential information about a financial offering, such as a bond or share issue. It acts like a comprehensive guide for investors, explaining what the investment involves, the risks involved, and how the process works. This helps investors make informed decisions before committing their money.
prospectus supplement regulatory
"a preliminary prospectus supplement, filed with the SEC on August 6, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
indemnify the Underwriter financial
"The Company and the Selling Stockholders have agreed to indemnify the Underwriter"
Offering Details
secondary
Offering
Offering Type
secondary
Use of Proceeds
The Company did not receive any proceeds from the sale of the shares offered by the Selling Stockholders.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock transaction did Innovex International (INVX) disclose on August 10, 2026?
Innovex disclosed a secondary offering of 5,000,000 common shares sold by affiliates of Amberjack Capital Partners through Barclays Capital Inc. Innovex itself did not sell shares and received no proceeds from this transaction.
Who were the selling stockholders and underwriter in Innovex’s (INVX) offering?
Affiliates of Amberjack Capital Partners, L.P. acted as the selling stockholders, and Barclays Capital Inc. served as the underwriter under an Underwriting Agreement dated August 6, 2026.
Under what registration statement was the Innovex (INVX) secondary offering made?
The offering was conducted under Innovex’s Form S-3 shelf registration statement, File No. 333-282178, which became effective on October 1, 2024 and was supplemented by prospectus supplements dated August 6 and August 10, 2026.